Skip Navigation LinksHome > May 1990 - Volume 75 - Issue 5 > Effect of Alpha1 Receptor Blockade Upon Maternal and Fetal C...
Obstetrics & Gynecology:
Original Article: PDF Only

Effect of Alpha1 Receptor Blockade Upon Maternal and Fetal Cardiovascular Responses to Cocaine.

DOLKART, LAWRENCE A. MD; PLESSINGER, MARK A. MS; WOODS, JAMES R. Jr MD

Collapse Box

Abstract

Previous studies in pregnant ewes have demonstrated that intravenous (IV) cocaine produces increased maternal blood pressure and vasoconstriction of the uterine arteries, resulting in decreased uterine blood flow and decreased fetal oxygen levels. To determine whether these responses to cocaine were mediated by [alpha]1-adrenergic receptor stimulation, cocaine was administered to four pregnant ewes before and after phenoxybenzamine hydrochloride, an [alpha]1 receptor antagonist. Before phenoxybenzamine infusion, cocaine 2.0 mg/kg produced a 53% increase in maternal mean arterial pressure (MAP), a 50% reduction in total uterine blood flow, and a 191% increase in uterine vascular resistance. Cocaine also increased fetal MAP by 24%, increased the fetal heart rate (FHR) by 51%, and reduced fetal PO2by 29%. Alpha1 receptor blockade after phenoxybenzamine 5.0 mg/kg was confirmed by a lack of change in uterine blood flow to IV norepinephrine 30 [mu]g before cocaine administration. After phenoxybenzamine, cocaine produced no increase in maternal or fetal MAP. However, total uterine blood flow decreased 44%, uterine vascular resistance increased 59%, FHR increased 36%, and fetal PO2 fell 18%. Because the fetal responses mimicked the maternal responses to cocaine both before and after phenoxybenzamine, phenoxybenzamine apparently crossed the placenta to block fetal [alpha]1 receptors as well. Alpha1-adrenergic receptor stimulation is the major mechanism for the maternal and fetal hypertensive responses to cocaine. Although cocaine produces uterine artery vasoconstriction primarily by [alpha]1 adrenergic receptor stimulation, its vasoconstrictive effects may involve other vasoactive neurotransmitters, such as dopamine or serotonin.

(C) 1990 The American College of Obstetricians and Gynecologists

Login

Article Tools

Share